ALKEM Stock View

Alkem Laboratories Ltd

ALKEM Stock View

(NSE)

Trade

₹ 4,647.9

-84.30 | -1.78

Market Cap ₹( Cr.)
555,726.20

Proj. P/E (x)
34.16

Proj. P/BV (x)
5.45

Proj. ROE (%)
16.96

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
128,160.59

HOLD

Last Updated On.
26-Nov-2023

 

Copy Link

Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Company’s product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data